137310 — SD Biosensor Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩1tn
- KR₩1tn
- KR₩695bn
- 72
- 46
- 57
- 64
Annual cashflow statement for SD Biosensor, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 621,614 | 1,064,432 | 908,789 | -467,904 | -98,140 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 131,148 | 360,466 | 516,751 | 309,209 | 58,756 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -265,354 | -209,068 | -576,126 | -221,164 | 54,217 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 495,382 | 1,234,945 | 890,233 | -242,319 | 156,527 |
| Capital Expenditures | -55,149 | -99,294 | -300,451 | -144,690 | -80,902 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -190,675 | -858,437 | 658,971 | -1,767,838 | -258,024 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -245,824 | -957,731 | 358,519 | -1,912,529 | -338,926 |
| Financing Cash Flow Items | -1,499 | 0 | -17,745 | 5,664 | 67.3 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -14,664 | 351,264 | -225,737 | 769,762 | -146,266 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 224,016 | 638,377 | 991,351 | -1,390,561 | -304,960 |